Clinical Trials Directory

Trials / Unknown

UnknownNCT03574025

NEUROlogical Prognosis After Cardiac Arrest in Kids

An Observational Study of Neurodevelopmental Outcome After Cardiac Arrest in Children Admitted to Paediatric Intensive Care in the United Kingdom and Ireland

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
University of Birmingham · Academic / Other
Sex
All
Age
24 Hours – 16 Years
Healthy volunteers
Not accepted

Summary

Each year around 2000 children have a cardiac arrest in the United Kingdom (UK) and approximately one fifth are admitted to Pediatric Intensive Care Unit. Many of these children eventually die and among those who survive, some will be left with brain damage which could affect their quality of life. Currently, it is difficult for doctors to predict how much brain damage there is at an early stage after cardiac arrest and if this will improve in time. NEURO-PACK aims to follow up children 3 months after their cardiac arrest to assess their quality of life and current functional status (has the child returned to usual routine as before cardiac arrest/mild disability, can the child not participate in certain activities as they were before the cardiac arrest/moderate disability, or if the child has near to no mobility/severe disability). Investigators will find this out by using a questionnaire and the research team will telephone patients and their families 3 months after the child's cardiac arrest. This telephone call should take no longer than 30 minutes. This will then be analysed and will help towards constructing a tool which will help doctors to predict which children who have had a cardiac arrest may survive with minimal brain damage.

Detailed description

Patients will be recruited from participating PICU's. There is currently lack of accurate data to enable clinicians to predict which of these children die or survive with brain injury. This affects clear communication with families as well as decisions to apply critical care interventions by clinicians. There is also an important knowledge gap with regards to outcome of children who are admitted to pediatric intensive care after a cardiac arrest and then survive to discharge. Inclusion Criteria: 1. Patients aged 24 hours up to 16th birthday 2. Requiring \> 1minute cardiopulmonary resuscitation 3. Admitted to PICU after Out of Hospital Cardiac Arrest or In Hospital Cardiac Arrest 4. Requiring mechanical ventilation at PICU admission 5. Surviving to 3 months follow up. Exclusion criteria: 1. Cardiac arrest occurring within a PICU or NICU (Neonatal Intensive Care Unit) 2. Clinical team at participating sites feel inclusion is inappropriate 3. Parent/ guardian or family member unable to understand the telephone questionnaires for outcome assessments in English The NEURO-PACK observational study enables the prospective collection of a cohort of children after out-of-hospital or in-hospital cardiac arrest. Data will be collected prospectively after eligible patients are screened and informed consent has been obtained. Participants and their families will be contacted by the Trials office,3 months after the patients cardiac arrest to complete a questionnaire over the telephone regarding functional status. Only contact information of the parents/guardians will be shared with the central Trials Office once informed consent has been obtained so that follow-up assessments can be completed. This information will be stored in locked cabinets, in a swipe card Trials Office based in Birmingham for five years, in line with Good Clinical Practice (GCP) guidance. The information collected from patients and their families will be analyzed and used to help construct a clinical prediction tool which will help clinicians to predict which children who have had cardiac arrest may survive with minimal brain damage.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireTo telephone the patient/family to look into how the patient is doing, moderate/severe brain damage.

Timeline

Start date
2018-01-01
Primary completion
2019-05-01
Completion
2019-08-01
First posted
2018-06-29
Last updated
2018-06-29

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03574025. Inclusion in this directory is not an endorsement.